Dynamic biomarker and imaging changes from a phase II study of pre‐ and post‐surgical sunitinib
British Journal of Urology2021cited by 7position: middledoi
A phase II clinical study evaluating the efficacy and safety of neoadjuvant and adjuvant sunitinib in previously untreated patients with metastatic renal cell carcinoma (mRCC)(NeoSun).
Journal of Clinical Oncology2017cited by 4position: middledoi